Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-25 @ 9:53 PM
Study NCT ID:
NCT04729751
Status:
COMPLETED
Last Update Posted:
2025-02-06
First Post:
2021-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
Sponsor:
Mirum Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-25
First Submit QC Date:
None
Study First Post Date:
2021-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-04
Last Update Post Date:
2025-02-06
Last Update Post Date Type:
ACTUAL